Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Too many people are expecting SVA to take off by late June

<< Previous

Bullboard Posts

Next >>

Comment by woundedkneeon May 31, 2021 7:31am

165 Views

Post# 33295182

RE:RE:RE:RE:RE:RE:Too many people are expecting SVA to take off by late June

So what are you referring to? We have no idea who Antibe is collaborating with as their CEO has just stated "many". I assume they are far from significant or the stock would be much higher. Obviously, Ventripoint's collab with GE is not a catalyst as their SP has droppef from the 60's to low 40's since the announcement. I'm not disputing what you say, but do not these I have mentioned have enough money or their names are not big enough? So we wait and wait and wait.

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December